Kristen K. Buck - Sep 1, 2022 Form 4 Insider Report for CALADRIUS BIOSCIENCES, INC. (LSTA)

Role
EVP, R&D and CMO
Signature
Kristen K. Buck, James Nisco, Attorney-in-Fact
Stock symbol
LSTA
Transactions as of
Sep 1, 2022
Transactions value $
-$5,980
Form type
4
Date filed
9/2/2022, 04:05 PM
Previous filing
Jan 12, 2022
Next filing
Jan 11, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LSTA Common Stock Award $29K +58K +18.17% $0.50* 377K Sep 1, 2022 Direct F1, F2
transaction LSTA Common Stock Tax liability -$12.6K -25.2K -6.68% $0.50* 352K Sep 1, 2022 Direct F2, F3
transaction LSTA Common Stock Tax liability -$22.4K -44.8K -12.72% $0.50* 307K Sep 1, 2022 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects 58,000 in performance rights, the criteria for which was satisfied on September 1, 2022 and which vested on the same date.
F2 Includes 257,750 of unvested restricted stock.
F3 Shares withheld as payment of a tax liability on vesting of performance rights.
F4 Shares withheld as payment of a tax liability on vesting of restricted stock.
F5 Includes 154,625 of unvested restricted stock.

Remarks:

Exhibit List: Exhibit 24, Power of Attorney.